Orthic helps small and mid-sized pharma manufacturers find their Schedule M gaps, fix them in a planned 60–90 day Sprint, and keep the evidence in one place with a tamper-evident audit trail.
Starting with manufacturers in Baddi, then Gujarat and Maharashtra.
Gap report · excerptIllustrative format
Requirement area and findingRisk
Pharmaceutical quality systemNo documented management review; quality objectives not setTo close: procedures and recordsHigh
Qualification and validationHVAC requalification overdue; no validation master planTo close: engineering and documentsHigh
Computerised systemsShared logins on lab software; audit trails never reviewedTo close: access control and an SOPHigh
Product quality reviewAnnual review not done for every productTo close: a schedule and a templateMedium
DocumentationBatch record corrections made without a reason recordedTo close: trainingMedium
An example of the format, not a client finding. Every gap is mapped to its Schedule M requirement, ranked by risk, with the work needed to close it.
Why now
Revised Schedule M applies to MSME plants today.
Revised Schedule M raised the GMP bar for every licensed manufacturer. Small and medium manufacturers, with turnover up to ₹250 crore, that filed an upgrade plan were given until 31 December 2025. That date has passed.
A documented pharmaceutical quality system and quality risk management
Qualification and validation of equipment, processes and utilities
Product quality reviews at least once a year
Controlled computerised systems: every change to a record logged, with backups and access control
Many gaps aren’t about new machines. They sit in documents, records and habits, and most can be found in a diagnostic and planned into a Sprint.
28 Dec 2023Revised Schedule M notifiedApplies to every licensed manufacturer
28 Jun 2024Deadline for larger manufacturersTurnover above ₹250 crore
31 Dec 2025Extended deadline for MSMEsFor those that filed an upgrade plan in Form A
TodayThe requirements apply to MSME plantsPlants without an extension had until 28 Dec 2024
Most plants start with a diagnostic. It tells you what is missing and what it will take, before you commit to anything bigger.
Start here
Schedule M gap diagnostic
₹1–1.5lakh
A plant visit and a document review against revised Schedule M. You get a written gap report with every finding ranked by risk, and a costed plan to close them.
The full fee is credited if you go on to a Sprint.
60–90 days to close the gaps from the diagnostic. We work alongside your QA team on SOPs, CAPAs, qualification and validation records, training and mock audits.
We don’t promise inspection outcomes or certification. That decision always rests with the regulator. We help you close the gaps and keep the evidence.
How the diagnostic works
From a 20-minute call to a ranked gap report.
01
20-minute call
We learn about your plant, dosage forms and recent inspection history, and you decide whether a diagnostic makes sense.
02
Proposal and NDA
A fixed fee and scope in writing, plus a mutual NDA before we see any document.
03
Document review
You share your quality manual, SOP index, recent CAPAs and validation master plan. We read them before the visit.
04
Plant visit
On site, we walk the areas, check records at the point of use and speak with QA, QC and production.
05
Gap report
Within 10 working days of the visit: every gap mapped to its Schedule M requirement, ranked by risk, with the effort needed to close it.
06
Walk-through
A call with your team on the report. If you choose a Sprint, the diagnostic fee is credited in full.
Who we work with
Plants that want a clear plan.
Formulation manufacturers with turnover up to ₹250 crore
Plants that have received an inspection observation, an NSQ report or a licensing query
Brand owners who want their contract manufacturers checked against revised Schedule M
About
Founder-led, based in Mumbai.
AA
Arjun Akshikar
Founder
Arjun grew up between Mumbai, Lagos, Istanbul and Madison and studied economics and political science at the University of Wisconsin–Madison. He started Orthic in 2026 to bring small and mid-sized pharma manufacturers the structured quality work that large companies get from in-house teams.
We are building a small team of experienced QA practitioners and engineers to work alongside plant teams.
Questions
What plant teams ask first.
Will this guarantee we pass an inspection?
No. Nobody can honestly promise that. We find the gaps, help you close them and keep the evidence ready for the inspector.
Do you replace our QA team?
No. We work alongside them, and the SOPs and records we help write stay yours.
Is our data safe?
We sign a mutual NDA before we see any document. Orthic software records every change in a tamper-evident audit trail, so you can see who changed what, and when.
Does the diagnostic fee go to waste if we don’t continue?
No. You keep the gap report and the plan. If you continue, the fee is credited to the Sprint.
Contact
Talk to us about your plant.
Tell us where the plant is, what you make and what prompted you to get in touch. Arjun replies within one working day.